Live Breaking News & Updates on Zhou yi

Stay informed with the latest breaking news from Zhou yi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Zhou yi and stay connected to the pulse of your community

HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session

HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shanghai , China , Japan , Hong-kong , Panmure , Victoria , Australia , United-states , American , Zhou-yi , Rui-hua-xu , Atholl-tweedie

HUTCHMED Highlights Presentation Of Phase III Data On Fruquintinib In Second-Line Gastric Cancer At ASCO Plenary Series Session

HUTCHMED Highlights Presentation Of Phase III Data On Fruquintinib In Second-Line Gastric Cancer At ASCO Plenary Series Session
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

China , Australia , Hong-kong , Japan , United-states , Shanghai , American , Rui-hua-xu , Ben-atwell-alex-shaw , Zhou-yi , Panmure-gordon , Linkedin

HUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnership

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 -- HUTCHMED Limited today announced that, Inmagene Biopharmaceuticals has exercised options to license two drug candidates...

China , Shanghai , Japan , Hong-kong , Weiguo-su , Crossley-daphne , Ben-atwell , Atholl-tweedie-freddy , Zhou-yi , Nasdaq , Exchange-commission , Linkedin

HUTCHMED Announces that Inmagene Exercises Option to

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...

Japan , Hong-kong , China , Shanghai , Zhou-yi , Ben-atwell , Atholl-tweedie-freddy , Crossley-daphne , Weiguo-su , Nasdaq , Exchange-commission , China-limited

HUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnership

HUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnership
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Japan , Shanghai , China , Hong-kong , Atholl-tweedie-freddy , Ben-atwell , Weiguo-su , Zhou-yi , Crossley-daphne , China-limited , Nasdaq , Stock-exchange-of-hong-kong

HUTCHMED to Announce 2023 Final Results

HUTCHMED to Announce 2023 Final Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shanghai , China , Hong-kong , Zhou-yi , Ben-atwell-alex-shaw , China-limited , Linkedin , Nasdaq , Eastern-standard-time , Greenwich-mean-time , Hong-kong-time , Alex-shaw

HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer

— First medicine approved under new “1+” mechanism by HKSAR Government, providing an important treatment option to patients in Hong Kong — — ELUNATE® is the first oral targeted therapy...

Hong-kong , Cairo , Al-qahirah , Egypt , United-states , Macau , Shanghai , China , Belgium , Belgian , American , Karen-atkin

HUTCHMED Receives ELUNATE® (fruquintinib) Marketing

— First medicine approved under new “1+” mechanism by HKSAR Government, providing an important treatment option to patients in Hong Kong — — ELUNATE® is...

Hong-kong , Belgium , Cairo , Al-qahirah , Egypt , Macau , United-states , China , Shanghai , Belgian , American , Stephen-chan

HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of ...

— First medicine approved under new “1+” mechanism by HKSAR Government, providing an important treatment option to patients in Hong Kong —

Hong-kong , Shanghai , China , Macau , United-states , Belgium , Cairo , Al-qahirah , Egypt , American , Belgian , Zhou-yi

Is Singapore's COE system due for 'significant reforms' as car prices reignite debate?

The COE car ownership system in Singapore remains a contentious issue despite recent easing from record-high prices.

Singapore , China , Singaporean , Singaporeans , Zhou-yi , Eugene-tan , Victor-kwan , Han-fook-kwang , Walter-theseira , Lianhe-zaobao , Progress-singapore-party , Singapore-institute-of-technology